1
/
of
1
Elabscience
SKU:PKSH031301
Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag)
Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag)
Regular price
$732.00 USD
Regular price
Sale price
$732.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag), a cutting-edge biotechnological advancement in the field of protein engineering. This meticulously crafted product combines the benefits of both His and Fc tags, resulting in a highly efficient and versatile protein with enhanced functionality.
The Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) is derived from state-of-the-art recombinant DNA technology, ensuring utmost purity and quality. This protein exhibits a unique dual-tag system, comprising the Histidine (His) tag and the Fc tag, which enables facile purification and improved stability.
With its exceptional binding affinity to Interleukin-22 (IL-22), the Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) acts as a potent antagonist, effectively inhibiting IL-22 signaling pathways. This attribute makes it an invaluable tool for researchers and scientists studying the intricate mechanisms of IL-22-mediated biological processes.
Furthermore, the inclusion of the Fc tag in this protein construct not only enhances its stability but also facilitates various downstream applications. The Fc tag enables effortless conjugation to other molecules, such as fluorescent dyes or enzymes, enabling a wide range of experimental possibilities.
The Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Its exceptional purity and bioactivity make it an ideal choice for a myriad of applications, including but not limited to protein-protein interaction studies, drug discovery, and therapeutic development.
In summary, the Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) represents a breakthrough in protein engineering, offering researchers an invaluable tool to unravel the complexities of IL-22 signaling pathways. Its dual-tag system, coupled with exceptional purity and bioactivity, make it an indispensable asset in the pursuit of scientific advancements and medical breakthroughs.
The Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) is derived from state-of-the-art recombinant DNA technology, ensuring utmost purity and quality. This protein exhibits a unique dual-tag system, comprising the Histidine (His) tag and the Fc tag, which enables facile purification and improved stability.
With its exceptional binding affinity to Interleukin-22 (IL-22), the Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) acts as a potent antagonist, effectively inhibiting IL-22 signaling pathways. This attribute makes it an invaluable tool for researchers and scientists studying the intricate mechanisms of IL-22-mediated biological processes.
Furthermore, the inclusion of the Fc tag in this protein construct not only enhances its stability but also facilitates various downstream applications. The Fc tag enables effortless conjugation to other molecules, such as fluorescent dyes or enzymes, enabling a wide range of experimental possibilities.
The Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) is meticulously manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Its exceptional purity and bioactivity make it an ideal choice for a myriad of applications, including but not limited to protein-protein interaction studies, drug discovery, and therapeutic development.
In summary, the Recombinant Human IL-22BP/IL22RA2 Protein (His & Fc Tag) represents a breakthrough in protein engineering, offering researchers an invaluable tool to unravel the complexities of IL-22 signaling pathways. Its dual-tag system, coupled with exceptional purity and bioactivity, make it an indispensable asset in the pursuit of scientific advancements and medical breakthroughs.
Share
